Primary Site >> Pancreatic Cancer

Gene >> CFH

Journal: Anticancer Res. 1999 Jul-Aug;19(4A):2459-69.
Title: Locoregional/systemic chemotherapy of locally advanced/metastasized pancreatic cancer with a combination of mitomycin-C and gemcitabine and simultaneous follow-up by imaging methods and tumor markers.
Author: Klapdor, R|Seutter, E|Lang-Polckow, E M|Reichle, H|Hinrichs, A
PMID: 10470175
Journal: Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):1089-96.
Title: Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
Author: Chakravarthy, A|Abrams, R A|Yeo, C J|Korman, L T|Donehower, R C|Hruban, R H|Zahurek, M L|Grochow, L B|O'Reilly, S|Hurwitz, H|Jaffee, E M|Lillemoe, K D|Cameron, J L
PMID: 11072167
Journal: Cancer. 2012 Jan 15;118(2):571-8.
Title: Identification of potential prognostic biomarkers in patients with untreated, advanced pancreatic cancer from a phase 3 trial (Cancer and Leukemia Group B 80303).
Author: Roberts, Andrew S|Campa, Michael J|Gottlin, Elizabeth B|Jiang, Chen|Owzar, Kouros|Kindler, Hedy L|Venook, Alan P|Goldberg, Richard M|O'Reilly, Eileen M|Patz, Edward F Jr
PMID: 21713765
Journal: Phys Med Biol. 2018 Jul 24;63(15):155003.
Title: Towards abdominal MRI-based treatment planning using population-based Hounsfield units for bulk density assignment.
Author: Hsu, Shu-Hui|Zawisza, Irene|O'Grady, Kyle|Peng, Qi|Tome, Wolfgang A
PMID: 29952320